Back
Novo Nordisk A/S Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
27
NVO
Novo Nordisk A/S
Last Price:
$48.02
Seasonality Move:
5.86%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
Novo Nordisk A/S Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.64 | Sell |
| 20-day SMA: | 47.86 | Sell |
| 50-day SMA: | 52.29 | Sell |
| 200-day SMA: | 63.28 | Sell |
| 8-day EMA: | 47.88 | Sell |
| 20-day EMA: | 48.57 | Sell |
| 50-day EMA: | 51.3 | Sell |
| 200-day EMA: | 64.96 | Sell |
Novo Nordisk A/S Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.12 | Sell |
| Relative Strength Index (14 RSI): | 43.87 | Sell |
| Chaikin Money Flow: | -3824156 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.77 - 49.67) | Sell |
| Bollinger Bands (100): | (48.46 - 60.6) | Sell |
Novo Nordisk A/S Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Novo Nordisk A/S Stock
Is Novo Nordisk A/S Stock a Buy?
-
Novo Nordisk A/S share price is 47.57 while NVO 8-day simple moving average is 47.64, which is a Sell signal.
-
The stock price of NVO is 47.57 while Novo Nordisk A/S 20-day SMA is 47.86, which makes it a Sell.
-
Novo Nordisk A/S 50-day simple moving average is 52.29 while NVO share price is 47.57, making it a Sell technically.
-
NVO stock price is 47.57 and Novo Nordisk A/S 200-day simple moving average is 63.28, creating a Sell signal.
NVO Technical Analysis vs Fundamental Analysis
Sell
27
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy or a Sell?
-
Novo Nordisk A/S stock is rated a SellThe current Novo Nordisk A/S [NVO] share price is $47.57. The Score for NVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk A/S Stock Info
Market Cap:
211.4B
Price in USD:
47.57
Share Volume:
11.5M
Novo Nordisk A/S 52-Week Range
52-Week High:
112.52
52-Week Low:
43.08
Sell
27
Novo Nordisk A/S (NVO)
is a Sell
Novo Nordisk A/S Share Price Forecast
-
What is the Novo Nordisk A/S stock price today?The Novo Nordisk A/S stock price is 47.57 USD today.
-
Will NVO stock go up or go down?Novo Nordisk A/S> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk A/S overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk A/S is overvalued.
Is Novo Nordisk A/S Stock a Buy?
-
Novo Nordisk A/S share price is 47.57 while NVO 8-day exponential moving average is 47.88, which is a Sell signal.
-
The stock price of NVO is 47.57 while Novo Nordisk A/S 20-day EMA is 48.57, which makes it a Sell.
-
Novo Nordisk A/S 50-day exponential moving average is 51.30 while NVO share price is 47.57, making it a Sell technically.
-
NVO stock price is 47.57 and Novo Nordisk A/S 200-day simple moving average is 64.96, creating a Sell signal.
Fundamental Analysis of Novo Nordisk A/S
Is Novo Nordisk A/S a good investment?
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Novo Nordisk A/S
Should I short Novo Nordisk A/S stock?
-
NVO Moving Average Covergence Divergence (MACD) indicator is -1.12, suggesting Novo Nordisk A/S is a Sell
-
Novo Nordisk A/S Relative Strength Index (RSI) is 43.87, which suggest Novo Nordisk A/S is oversold
-
The Bollinger Bands (25) for Novo Nordisk A/S is (46.77 - 49.67), which suggest Novo Nordisk A/S is a Sell
-
The Bollinger Bands (100) for Novo Nordisk A/S is (48.46 - 60.6), which suggest Novo Nordisk A/S is a Sell
* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.